NOTCH3 Modulates Inflammation and Fibrosis in HK2 Cells Under Diabetic Conditions Through TLR4/NF‐κB and TGF‐β1/Smad3 Signaling
Journal of Biochemical and Molecular Toxicology · 2026
DOI: 10.1002/jbt.70984 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2026. Verfasst von RunHua Tian und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, The Affiliated Hospital of Qingdao University, Qingdao City, Shandong Province, China. Hauptthemen laut MEDLINE: Smad3 Protein, Transforming Growth Factor beta1, Signal Transduction, NF-kappa B. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
To investigate the modulatory role of NOTCH3 in renal inflammatory and fibrotic processes during diabetic nephropathy (DN), focusing on TLR4/NF‐κB and TGF‐β1/Smad3 signaling pathways. HK2 cells were stimulated with BSA to mimic diabetic conditions in vitro . To investigate the roles of TLR4/NF‐κB and TGF‐β1/Smad3 pathways, cells were treated with Resatorvid or LPS, and SB‐431542 or TGF‐β1, respectively. Also, HK2 cells were transfected with siRNA knockdown and pcDNA 3.1 overexpression vectors targeting NOTCH3. After treatments, cell viability, LDH release, inflammatory factors, apoptosis, and levels of fibrotic markers were analyzed. BSA stimulation upregulated NOTCH3 expression in HK2 cells. Silencing NOTCH3 enhanced viability and reduced LDH release, secretion of inflammatory factors, apoptosis, and fibrotic marker expression. Conversely, NOTCH3 overexpression exacerbated BSA‐induced cellular injury, inflammatory responses, and fibrotic marker expression. NOTCH3 also enhanced activation of the TLR4/NF‐κB and TGF‐β1/Smad3 pathways, and inhibition of either pathway partially mitigated the effects of NOTCH3 overexpression. Furthermore, in NOTCH3 knockdown cells, co‐treatment with downstream activators partially restored inflammatory and fibrotic responses, supporting the modulatory role of NOTCH3 in coordinating these signaling pathways. NOTCH3 modulates renal inflammation and fibrosis in BSA‐stimulated HK2 cells via the TLR4/NF‐κB and TGF‐β1/Smad3 pathways, highlighting its potential as a modulator of inflammatory and fibrotic responses in DN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, The Affiliated Hospital of Qingdao University, Qingdao City, Shandong Province, China.
- Department of Clinical Laboratory, Qingdao Women and Children's Hospital, Qingdao City, Shandong Province, China.
ORCID-Profile: ChunXi Zheng
Zitieren
APA
Tian, R., & Zheng, C. (2026). NOTCH3 Modulates Inflammation and Fibrosis in HK2 Cells Under Diabetic Conditions Through TLR4/NF‐κB and TGF‐β1/Smad3 Signaling. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70984
Vancouver
Tian R, Zheng C. NOTCH3 Modulates Inflammation and Fibrosis in HK2 Cells Under Diabetic Conditions Through TLR4/NF‐κB and TGF‐β1/Smad3 Signaling. Journal of Biochemical and Molecular Toxicology. 2026. doi:10.1002/jbt.70984
BibTeX
@article{Tian2026,
author = {Tian, RunHua and Zheng, ChunXi},
title = {NOTCH3 Modulates Inflammation and Fibrosis in HK2 Cells Under Diabetic Conditions Through TLR4/NF‐κB and TGF‐β1/Smad3 Signaling},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2026},
doi = {10.1002/jbt.70984}
}
EUVIMED